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an immune-mediated mechanism in delayed radiation 
injury to the brain, principally because of inflammatory 
infiltrates that are so frequently seen on microscopical 
examination IS, 10, 11). Recently, Hart and associates 
131 demonstrated that cerebral vasculitis can be pro- 
duced by transfer of lymphocytes activated in vivo or 
in vitro after exposure to cerebral capillary endothelial 
cells. Endothelial cells injured or altered by radiation 
may also be capable of serving as a source of antigen to 
initiate a cerebral vasculitis. 
Several approaches can be envisioned to define 
whether immune-mediated mechanisms contribute to 
the pathogenesis of delayed radiation necrosis. First, 
human biopsy or autopsy material can be studied im- 
munohistochemically to search for antibody, comple- 
ment, or immune complex localization. Second, the 
possibility of an immune contribution should be 
studied in a more controlled setting in experimental 
animals, in which models of radiation vasculitis have 
been developed 17, 1 1). If an immune mechanism con- 
tributes in any way to the pathogenesis of delayed radi- 
ation necrosis, then immunosuppressive therapy may 
be beneficial in radiation brain injury. 
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Increased Leukotriene Cq - 
and Vasogenic Edema 
Surrounding Brain Tumors 
in Humans 
Keith L. Black, MD," Julian T. Hoff, MD," 
John E. McGillicuddy, MD," 
and Stephen S. Gebarski, MD'F 
Leukotrienes are pharmacologically active compounds 
that promote vascular permeability. In this study we 
sought to determine whether tissue leukotriene-like im- 
munoreactivity was increased in intracranial tumors as- 
sociated with peritumoral edema. In 20 patients under- 
going craniotomy tissue specimens were immediately 
frozen after removal and tissue leukotriene C4 levels 
were determined by radioimmunoassay. An index of 
peritumoral edema was estimated from preoperative 
contrast-enhanced computed tomographic scans. There 
was a significant correlation between brain edema and 
tissue leukotriene levels ( p  < 0.003). Metastatic tumors 
(n = 8) had the highest leukotriene C4 level at 13.8 f 
8.5 pg/mg tissue (mean 2 SE) and the highest index of 
edema 5.7 2 1.8. The mean leukotriene C4 level in the 
gliomas (n = 5 )  was 6.2 +- 2.3 pg/mg tissue and the 
edema index was 2.1 2 0.6. There was no edema and no 
neoplasm in the temporal lobes removed for seizure (n 
= 2), and their level of leukotriene C4 was 0.4 2 0.1 pg/ 
mg tissue. The formation of leukotriene C4 is stimulated 
by intracranial tumors. Leukotrienes increase blood- 
brain barrier permeability and may be important in the 
formation of vasogenic edema surrounding tumors. 
Black KL, Hoff JT, McGilIicuddy JE, Gebarski SS: 
Increased leukotriene C4 and vasogenic 
edema surrounding brain tumors in humans. 
Ann Neurol 19:592-595, 1986 
Leukotrienes (LTs) are biologically active hydroxy 
lipids (LTB4) and peptidolipids (LTC4, D4, and E4) 
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formed from the unsaturated fatty acid arachidonic 
acid 1141. Leukotrienes have been shown to increase 
vascular permeability in postcapillary venules El, IS}, 
elicit erythema and wheal formation in skin {lb}, and 
produce coronary {lo} and cerebral {17} vasoconstric- 
tion. We recently demonstrated that leukotriene B4, 
C4, or E4 injected directly into brain parenchyma will 
significantly increase blood-brain barrier permeability, 
and we speculated that leukotdenes may be important 
in the generation of vasogenic brain edema E2, 31. 
Since intracerebral neoplasms produce vasogenic brain 
edema, we sought to determine if leukotrienes could 
contribute to the development of peritumoral vaso- 
genic edema. 
Materials and Methods 
Brain or tumor tissue was obtained from 20 patients under- 
going craniotomy. Tissue was obtained from 8 patients with 
metastatic tumors, 5 patients with gliomas, 4 patients with 
meningromas, 1 patient with a schwannoma, and 2 patients 
undergoing temporal lobectomy for seizures. Patients under- 
going temporal lobectomy were considered controls since 
there was no evidence of neoplasm, infection, or injury on 
pathological examination. Tissue sample size ranged from 
0.12 to 1.6 gm. In some patients several biopsies were ob- 
tamed, including normal adjacent brain tissue, tumor periph- 
ery, and tumor core. 
After removal, surgical specimens were immediately fro- 
zen in pentane that was cooled in dry ice. Samples were 
stored at - 70°C until tissue extraction. Tissue LTC4 levels 
were determined by radioimmunoassay using the New En- 
gland Nuclear leukotriene Cq [ 3H)ra&oimmunoassay kit 
(New England Nuclear, Boston, MA). The separation of 
antibody-antigen complexes from free antigen was achieved 
by the absorption of the free 3H tracer onto activated char- 
coal. The tissue samples were extracted using prostaglandin 
extraction methods previously described [4}. The limit of 
sensitivity was 3.7 pg per tube. The antibody cross-reacts 
55% with LTD4 and 8.6% with LTE4. The cross-reactivity to 
LTB4, prostaglandins, or unsaturated fatty acids was 0.006% 
or less. 
Brain edema was determined from preoperative contrast- 
enhanced computed tomograms (CT) by a neuroradiologist 
(S. S. G.) who was unaware of the brain leukotriene levels. 
The tumor area was determined by measuring the maximum 
tumor diameter and the longest diameter perpendicular to 
the maximum diameter. From these two measurements an 
averaged diameter was determined and divided by 2 to ap- 
proximate the average radius. For estimation of area, the 
tumor was assumed to represent a plane through the equator 
of a sphere. The averaged radius was squared and multiplied 
by IT. The total abnormal area (tumor area plus edema area) 
was also determined by the same method. An edema index 
was then calculated by dividing the total abnormal area by 
the tumor area. Since a small neoplasm with a large area of 
surrounding edema could have the same absolute area of 
edema as a large tumor with a relatively small area of sur- 
rounding edema, we believe an edema index, which rep- 
resents the ratio of edema to tumor size, is a better char- 
acterization of the edema surrounding a neoplasm. This 
determination yields similar results whether tumor area or 
tumor volume is measured. 
Results 
Metastatic tumors and gliomas had a significant amount 
of peritumoral edema (edema index, 5.7 s 1.8 and 2.1 
* 0.6, respectively) and high LTC4 levels (13.8 s 8.5 
and 6.2 k 2.3 pglmg tissue, respectively). There was 
no edema and no neoplasm in the temporal lobes re- 
moved for seizure (controls), and the LTC4 level was 
0.4 k 0.1 pglmg tissue (Table). One patient with a 
metastatic tumor had received radiation therapy three 
months prior to craniotomy. His CT scan prior to op- 
eration showed no peritumoral edema. The LTC4 level 
in this patient was 0.16 pglmg tissue. A second patient 
with a metastatic tumor had an edema index of 1.1 and 
an LTC4 level of 1.9 pglmg tissue. All other patients 
with metastatic tumor had an edema index of 1.6 to 
12.8 and LTC4 levels that ranged from 2.4 to 72.2 pgl 
mg tissue. In one patient with a schwannoma, without 
surrounding edema, an area of normal cerebellum was 
resected to expose the tumor. This cerebellar tissue 
had an LTC4 level of 0.7 pglmg brain and it is included 
with the control temporal lobes in the Table. 
In order to satisfy the statistical assumptions of the 
analysis-of-variance model, analysis was done on the 
natural logarithm of the LTC4 levels. There was a 
significant correlation between edema and the log 
LTC4 levels with p < 0.003 and a correlation co- 
efficient of 0.62185 (Figure). An analysis of covariance 
with edema as the dependent variable and the log 
LTC4 as the covariable also revealed a significant rela- 
tionship between the log LTC4 and edema within the 
group distribution (p < 0.02) but no difference in the 
log LTC4 levels between the groups. 
In two patients with metastatic tumors and two pa- 
tients with gliomas, nonneoplastic brain tissue im- 
mediately adjacent to the tumor was analyzed. The 
LTC4 level in this tissue was 3.6 t 1.1 (mean k SE). 
This was significantly higher than the level in the con- 
trol brain tissue at p < 0.003 using the two-sample t 
Leukotraene C4 Level and In& of Edema Szm-ounding 
Brain Tumors and Nonneopksstic Controls (mean * SE) 
LTC4 Level 
Tumor Type (pdmg tissue) Edema Index 
Controls (n = 3) 0.5 2 0.1 1.0 r 0.0 
Metastatic tumors (n = 8) 5.7 t 1.8 
Gliomas (n = 5 )  6.2 ? 2.3 2.1 ? 0.6 
Meningiomas (n = 4 )  0.6 ? 0.2 1.6 ? 0.7 
13.8 _t 8.5 
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Graph showing relationship between the natural logarithm of 
the leukotriene C4 (LTC4) level and the edema zndex for all pa- 
tients. There is a significant correlation between log LTC, and 
edema at p < 0.003. The LTC4 values are expressed as log 
LTC4 t o  satisfy the statistical assumptions of the anahsis-of- 
variance model. 
test. We have included in the Table only LTC4 levels 
for the tumor itself. 
Discussion 
Brain lipids are rich in arachidonic acid. During cere- 
bral injury membraine-bound arachidonic acid is re- 
leased and the tissue content of free arachidonate can 
increase 20- to 40-fold [ 123. Free arachidonic acid has 
been shown to produce vasogenic brain edema in a 
dose-dependent manner [GI. Free arachidonic acid is 
oxidized via two pathways: cyclooxygenase, leading to 
the formation of prostaglandins; and 5-lipoxygen- 
ase, leading to the formation of leukotrienes. We re- 
cently demonstrated that vasogenic edema induced by 
arachidonic acid can be prevented by pretreatment 
with a 5-lipoxygenase inhibitor, BW755C [3-amino-l- 
(3-trifluoromethylphenyl)-2-pyrazoline~, but not by 
indomethacin, an inhibitor of cyclooxygenase [ 3 ] .  This 
suggests that the ability of arachidonic acid to increase 
blood-brain barrier permeability is dependent on the 
formation of 5-lipoxygenase products (i.e., leuko- 
trienes). Furthermore, we have shown that nanogram 
quantities of pure leukotrienes injected directly into 
brain significantly increase blood-brain barrier perme- 
ability 12, 31. These observations taken together sug- 
gest that leukotrienes may be important in the forma- 
tion of vasogenic brain edema. 
Chan and co-workers (61 suggested that the ability 
of arachidonic acid to produce brain edema is not 
specific. They also reported increased edema after in- 
jections of linolenic acid, but not saturated fatty acids. 
Homa and colleagues IS}, however, recently reported 
that polyunsaturated fatty acids, but not saturated fatty 
acids, stimulate the formation of lipoxygenase products 
from arachidonic acid. Therefore, theoretically, lino- 
lenic acid might increase edema by increasing the COR- 
version of arachidonic acid to leukotrienes. Because 
the 5-lipoxygenase enzyme accepts a variety of polyun- 
saturated fatty acids as substrate, fatty acids with 19 tb 
21  carbons and with 3 or more unconjugated double 
bonds are converted to leukotrienes by the lipoxygen- 
ase enzyme. 
Leukocytes and platelets are rich in the lipoxygenase 
enzyme and are known to accumulate in cerebral in- 
jury. The major pathway for arachidonic acid metabo- 
lism in leukocytes is via 5-lipoxygenase I131. Platelets 
will convert arachidonic acid via 12-lipoxygenase to 
12-~-hydroperoxy-5,8,10,14-eicosatetraenoic acid (12- 
HPETE). The 5-lipoxygenase enzyme is, in turn, ac- 
tivated by 12-HPETE [15] as well as prostaglandin 
endoperoxides r73, and the rate of arachidonic acid 
oxygenation by lipoxygenase is increased. 
The tissue element or elements responsible for the 
conversion of arachidonic acid to leukotrienes in brain, 
however, has not been clearly defined. Moskowitz et al 
I1 11 suggested that leukotrienes were formed in brain 
gray matter. In support of this, leukotrienes Cq, D4, 
and E4 have been isolated after incubation of rat brain 
tissue with the ionophore A23 187 and arachidonic 
acid in vitro 191. We have demonstrated that severe 
leukopenia does not prevent arachidonic acid-induced 
vasogenic edema, which suggests that leukocytes may 
not be the major source for brain leukotriene produc- 
tion (unpublished observation, 1985). 
Vasogenic edema associated with brain tumors, par- 
ticularly metastatic and glial tumors, contributes to 
morbidity and mortality. We report here increased 
levels of LTC4-like immunoreactivity in brain tumors 
with peritumoral edema and suggest that one mecha- 
nism for peritumoral edema formation may be the 
elaboration of leukotrienes. 
Meningiomas had low LTC4 levels and less edema 
than did metastatic tumors or gliomas. The LTC4 level 
in meningiomas, however, appeared disproportion- 
ately low. Unlike gliomas or metastatic tumors, menin- 
giomas are extraaxial tumors and leukotriene forma- 
tion in association with these tumors may occur in the 
brain parenchyma adjacent to the tumor rather than in 
the meningioma itself. We did not sample brain tissue 
adjacent to meningiomas. 
Glucocorricoids reduce peritumoral edema 1191. 
Glucocorticoids also inhibit the release of free arachi- 
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donic acid, probably through the inhibition of phos- 
pholipase A*, and reduce the formation of leuko- 
trienes 157. One mechanism by which glucocorticoids 
reduce vasogenic edema, therefore, may be through 
the reduction of leukotrienes. 
Leukotrienes increase blood-brain barrier perme- 
ability, and we have observed that brain tumors stimu- 
late the formation of LTC4-like immunoreactivity. Al- 
though we believe the formation of brain edema is 
multifqctorial, we suggest that leukotrienes are irnpor- 
tant in the formation of vasogenic brain edema. Selec- 
tive inhibition of the 5-lipoxygenase enzyme could re- 
duce peritumoral edema. 
14. Samuelsson B, Paoletti R (eds): Leukotrienes and Other Lipoxy- 
genase Products. New York, Raven, 1982 
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Kernicterus in an Adult 
Marco Waser, MD,* Paul Kleihues, MD," 
and Paul Frick. M D t  
A 43-year-old woman was initially seen because of ic- 
terus. Clinical investigations revealed severe hepatic 
damage probably due to non-A, non-B hepatitis. She 
was treated with extracorporeal charcoal-column perfu- 
sion but died two weeks later in a hepatic coma. At 
autopsy, the brain showed kernicterus with typical dis- 
coloration of the hippocampus, the subthalamic nuclei, 
and the cerebellar dentate nuclqi. Kernicterus in an 
adult is very rare. In this case, extracorporeal charcoal- 
column perfusion treatment led repeatedly to severe 
depletion of fibrinogen, with extensive hemorrhages. 
Overload of the already reduced hepatic glucuronyl- 
transferase capacity resulted in high serum levels of un- 
conjugated bilirubin, an apparent prerequisite for the 
development of bilirubin encephalopathy. 
Waser M, Kleihues P, Frick P: Kernicterus in 
an adult. A n n  Neurol 19:595-598, 1986 
The term kernicterus refers to bilirubin encephalopathy 
in children with icteric discoloration of the basal gan- 
glia, especially the globus pallidus, the hippocampus, 
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